GAD-7 Anxiety Score Calculator
Score the GAD-7 anxiety questionnaire.
Returns a total from 0-21 with minimal, mild, moderate, or severe ratings and recommended next steps for each level.
What the GAD-7 is — and isn’t
The GAD-7 is a 7-item screening questionnaire for generalized anxiety disorder, developed by Robert Spitzer, Kurt Kroenke, Janet Williams, and Bernd Löwe at Columbia University in 2006. It’s now the single most-used anxiety screening tool worldwide in primary care, behavioral health, and research settings.
It’s a screening tool, not a diagnostic instrument. A high score signals “worth investigating further” — it doesn’t itself diagnose generalized anxiety disorder. Diagnosis requires a clinical interview with a qualified mental health professional, using DSM-5-TR or ICD-11 criteria.
The full validated reference is: Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-1097.
The 7 questions
Each asks about the past 2 weeks. Rate frequency 0-3:
- Feeling nervous, anxious, or on edge
- Not being able to stop or control worrying
- Worrying too much about different things
- Trouble relaxing
- Being so restless that it is hard to sit still
- Becoming easily annoyed or irritable
- Feeling afraid as if something awful might happen
Scoring scale
| Score | Meaning |
|---|---|
| 0 | Not at all |
| 1 | Several days |
| 2 | More than half the days |
| 3 | Nearly every day |
Total possible: 0-21.
Severity interpretation
| Total score | Severity | Suggested action |
|---|---|---|
| 0-4 | Minimal anxiety | No clinical concern |
| 5-9 | Mild anxiety | Watchful waiting; lifestyle changes |
| 10-14 | Moderate anxiety | Suggests further evaluation |
| 15-21 | Severe anxiety | Likely benefits from active treatment |
The score of 10 is the standard “positive screen” cutoff. Above this threshold, sensitivity for GAD diagnosis is ~89% and specificity ~82% (Spitzer et al., 2006).
What anxiety looks like clinically
Generalized anxiety disorder (DSM-5-TR diagnosis) requires:
- Excessive worry about multiple topics, more days than not, for 6+ months
- Difficult to control the worry
- At least 3 of 6 physical symptoms: restlessness, fatigue, difficulty concentrating, irritability, muscle tension, sleep disturbance
- Clinically significant distress or impairment
- Not explained by substance use, medical condition, or other mental disorder
The GAD-7 captures the cognitive worry symptoms well but is less sensitive to physical symptoms.
Comorbidity is the rule, not the exception
In primary care patient populations, of those screening positive for GAD:
- 60-70% also meet criteria for major depression
- 30-40% have a comorbid panic disorder, social anxiety, or specific phobia
- 25% have a comorbid alcohol or substance use disorder
- 30% have a chronic medical condition that worsens with anxiety (chronic pain, asthma, GI disorders)
This is why most clinicians administer GAD-7 alongside PHQ-9 (depression screening). The two tools are designed to work together.
Why anxiety is dramatically under-treated
Despite ~31% of US adults experiencing an anxiety disorder at some point (NIMH data), only about 37% of those affected receive any treatment. Reasons:
- Stigma — anxiety is “weakness”
- Cultural acceptance — “everyone has stress”
- Inadequate primary care screening
- Confusion between situational stress and clinical anxiety
- Lack of insurance coverage for therapy
- Long waitlists (often 3-6 months for therapy in US)
- Misdiagnosis (anxiety often presents as physical complaints: chest pain, GI issues, fatigue)
A positive GAD-7 score is the gateway to actual treatment for many people who didn’t realize their experience had a clinical name.
Treatment options for moderate-severe anxiety
Evidence-based first-line treatments:
- Cognitive Behavioral Therapy (CBT) — 8-12 sessions; effect size 0.8-1.2 (large)
- SSRI medications — sertraline, escitalopram, paroxetine; effect size ~0.3-0.5 (moderate)
- SNRI medications — venlafaxine, duloxetine; similar effect size
- Combination CBT + medication — better than either alone for severe cases
- Mindfulness-based stress reduction (MBSR) — comparable to CBT in some studies, especially for mild-moderate
Less evidence-supported but commonly used:
- Benzodiazepines (Xanax, Ativan, Klonopin) — fast-acting but addictive; usually not first-line for chronic anxiety
- Buspirone — non-addictive but slow onset, modest effect
- Beta blockers (propranolol) — useful for performance anxiety specifically
- Cannabis/CBD — mixed evidence; can paradoxically worsen anxiety in many users
- Herbal remedies (kava, valerian, passionflower) — minimal evidence
Self-help interventions that genuinely work
Even at mild anxiety levels (GAD-7 5-9), these have evidence behind them:
- Aerobic exercise — 30 min, 3x/week. Effect size 0.5-0.7 for anxiety reduction
- Reduce caffeine — many people don’t realize 3+ cups/day causes physiological anxiety
- Limit alcohol — alcohol withdrawal (even mild) causes anxiety rebound
- Sleep hygiene — chronic sleep deprivation precipitates anxiety
- Mindfulness apps (Calm, Headspace, Waking Up) — 10 min/day for 8+ weeks
- Limit news/social media — particularly distressing content
- Strong social connections — isolation worsens anxiety
When anxiety becomes an emergency
Seek immediate help if:
- Thoughts of suicide or self-harm
- Panic attacks lasting >30 minutes or repeating
- Cannot function (work, school, basic self-care)
- Significant weight loss/gain from anxiety-driven changes in eating
- Substance use as a coping mechanism
In the US: 988 Suicide & Crisis Lifeline (call or text) In the UK: Samaritans 116 123 In Australia: Lifeline 13 11 14
The “anxiety doesn’t have to be debilitating” perspective
For many people, anxiety is genuinely treatable. The mean response to CBT in GAD studies is ~60-70% achieving remission within 12 weeks. SSRIs help ~50-60% of those who try them. Most people who get treatment improve significantly — and most don’t seek treatment.
If the GAD-7 score concerns you, the most useful single step is talking to a primary care physician or therapist. Even a 30-minute initial consultation can dramatically clarify whether what you’re experiencing fits clinical anxiety and what to do about it.
Tracking over time
The GAD-7 is most useful as a tracking tool, not a one-time snapshot. Many therapists administer it at every session to measure treatment progress. A drop from 15 to 7 over 12 weeks of CBT is a meaningful clinical improvement; a drop from 8 to 5 may not be.
Limitations of the GAD-7
- Self-report only — vulnerable to underreporting (stigma) or overreporting (anxious about anxiety)
- Doesn’t distinguish well between anxiety subtypes (GAD vs panic vs social vs OCD)
- 2-week window may miss episodic patterns
- Different cultural contexts can affect scoring (worry valence differs across cultures)
- Not validated for ages under 18 (use GAD-7 for adolescents 13-18 has separate validation studies)
Disclaimer (important)
This calculator is for educational and screening purposes only. It is not a diagnostic instrument, does not substitute for professional evaluation, and should not be used to self-diagnose or to determine treatment. If your score concerns you, please consult a healthcare provider. The GAD-7 itself is copyright Pfizer Inc., released for educational and clinical use under a permissive license.
Bottom line
The GAD-7 takes 2 minutes, gives you a number from 0-21, and meaningfully predicts whether further evaluation is warranted. A score of 10+ is the standard cutoff for “worth a closer look.” A score of 15+ suggests severe anxiety likely benefiting from active treatment. Most anxiety is treatable; most untreated anxiety stays that way for years.